China approves clinical trials on vaccine for virus

China approved start of clinical trials on a vaccine for new coronavirus on Monday.

recombinant vaccine for disease COVID-19, was developed by China's Acemy of Military Medical Sciences in Wuhan, China's Central Television (CCTV) reported.

Chen Wei, leer of research team at acemy, said all preparations h been me for vaccine's "safety, effectiveness, controllable quality and mass production".

China's National Medical Products ministration approved start of clinical trials after a review meeting on Monday afteron, CCTV said.

Chen's team carried out relevant researches on safety pharmacology, pharmacodynamics, general toxicology and ors, on basis of ir prior success in developing an Ebola vaccine, according to CCTV.

For most people, new coronavirus causes only mild or moderate symptoms, such as fever and cough. For some, especially older ults and people with existing health problems, it can cause more severe illness, including pneumonia.

vast majority of people recover from new virus. According to World Health Organization, people with mild illness recover in about two weeks, while those with more severe illness may take three to six weeks to recover.

Worldwide coronavirus pandemic has infected more than 198,000 people and killed more than 7,900.

More than 81,000 people have recovered so far, mostly in China.